查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2029 年肝轉移藥物全球市場規模調查和預測，按原發性癌症、類型、分銷渠道、地區分析
市場調查報告書
商品編碼
1251569

2022-2029 年肝轉移藥物全球市場規模調查和預測，按原發性癌症、類型、分銷渠道、地區分析

Global Liver Metastases Treatment Market Size study & Forecast, by Type by Primary Cancer, by Distribution Channel and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

2021 年全球肝轉移藥物市場價值約為 12 億美元，預計在 2022-2029 年預測期內將以超過 7.2% 的健康增長率增長。

肝轉移是指原發腫瘤或癌症轉移至肝臟。 肝轉移不是從肝臟開始，而是從其他受影響的區域擴散。 已經擴散到肝臟的癌症會導致肝轉移。 肝轉移瘤的治療是用來治癒肝轉移瘤的方法。 轉移到肝臟的典型癌症包括乳腺癌、結腸癌、食道癌和肺癌。 乳腺癌和結直腸癌病例數量的增加、政府對癌症治療的支持和承諾的增加、研發的進步、目標疾病發病率的上升等都是推動市場增長的因素。

根據世界癌症研究基金會的數據，2020年全球乳腺癌患者人數約佔12.5%，而肺癌患者人數約佔12.2%。 2020年大腸癌新增病例190萬，在所有癌症類型中排名第三，佔所有病例的10.7%。 此外，世界衛生組織於 2023 年 2 月宣布了一項新的全球乳腺癌框架，以實現到 2040 年避免 250 萬例乳腺癌死亡的目標。 乳腺癌和結直腸癌病例的增加、政府支持和舉措的增加是推動市場增長的主要因素。 此外，研發的進步和目標疾病發病率的上升也是推動市場擴張的重要因素。 在預測期內，肝轉移治療的技術進步和醫療保健研發的增加正在創造巨大的市場機會。 然而，肝轉移藥物的高成本將阻礙整個 2022-2029 年預測期內的市場增長。

全球肝轉移藥物市場研究考慮的主要區域是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 由於先進的癌症治療方案的可用性、政府對癌症的有利政策以及美國等國家肝轉移的高患病率，北美在收入方面佔據了市場主導地位。 例如，據說美國每年約有140,000例肝轉移病例。 由於醫療成本上升、醫療設施便利以及缺乏有效篩查等因素，預計亞太地區在預測期內將以最高複合年增長率增長。

內容

第 1 章執行摘要

  • 市場概況
  • 2019-2029 年各細分市場的全球市場估計和預測
    • 肝轉移藥物市場，按地區劃分，2019-2029 年
    • 肝轉移藥物市場，按類型，2019-2029
    • 肝轉移藥物市場，按原發性癌症分類，2019-2029 年
    • 肝轉移藥物市場，按分銷渠道，2019-2029 年
  • 主要趨勢
  • 調查方法
  • 調查先決條件

第2章全球肝轉移藥物市場的定義和範圍

  • 調查目的
  • 市場定義和範圍
    • 調查範圍
    • 工業發展
  • 本次調查涵蓋的年份
  • 貨幣兌換率

第三章全球肝轉移藥物市場動態

  • 肝轉移藥物市場影響分析（2019-2029）
    • 市場驅動因素
      • 乳腺癌和結直腸癌患者人數增加
      • 政府加大對癌症治療的支持和力度
    • 市場挑戰
      • 肝轉移治療費用高
    • 市場機會
      • 肝轉移治療技術進展
      • 激活醫療保健領域的研發

第四章肝轉移藥物全球市場行業分析

  • 波特 5 力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係
  • 波特 5 力模型的未來方法 (2019-2029)
  • 害蟲分析
    • 政治
    • 經濟的
    • 社交
    • 技術
  • 投資招聘模式
  • 分析師的建議和結論
  • 最佳投資機會
  • 關鍵成功策略

第 5 章風險評估 COVID-19 影響

  • 評估 COVID-19 對行業的總體影響
  • COVID-19 之前和 COVID-19 之後的市場情景

第 6 章全球肝轉移藥物市場：按類型分類

  • 市場概況
  • 肝轉移藥物的全球市場：按類型和性能分類 - 潛力分析
  • 2019-2029 年按類型分列的全球肝轉移藥物市場估計和預測
  • 肝轉移藥物市場，細分市場分析
    • 化療
    • 靶向治療
    • 免疫療法

第 7 章。肝轉移藥物的全球市場：按原發性癌症分類

  • 市場概況
  • 用於治療肝轉移的藥物的全球市場：按原發性癌症、按性能）- 潛力分析
  • 2019-2029 年全球原發癌肝轉移藥物市場預估與預測
  • 肝轉移治療市場，按細分市場分析
    • 結直腸癌
    • 乳腺癌

第 8 章全球肝轉移藥物市場：按分銷渠道

  • 市場概況
  • 肝轉移藥物的全球市場：按分銷渠道進行的性能潛力分析
  • 2019-2029 年肝轉移藥物的全球市場估計和預測（按分銷渠道）
  • 肝轉移藥物市場，細分市場分析
    • 醫院藥房
    • 專業藥房

第 9 章全球肝轉移藥物市場：區域分析

  • 肝轉移治療市場，按地區劃分的市場概況
  • 北美
    • 美國
      • 按類型估算和預測，2019-2029 年
      • 原發性癌症的估計和預測，2019-2029 年
      • 2019-2029 年各分銷渠道的估計和預測
    • 加拿大
  • 歐洲肝轉移藥物市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲
  • 亞太地區肝轉移藥物市場概況
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲肝轉移藥物市場概況
    • 巴西
    • 墨西哥
  • 世界其他地方

第 10 章衝突信息

  • 頂級市場策略
  • 公司簡介
    • F. Hoffmann-La Roche Ltd.
      • 關鍵信息
      • 概覽
      • 財務（僅當數據可用時）
      • 產品概述
      • 近期趨勢
    • AstraZeneca
    • Bayer AG
    • Eli Lilly and Company
    • Ono Pharmaceutical
    • Pfizer, Inc.
    • Bristol-Myers Squibb Company
    • Cadila Pharmaceuticals Ltd.
    • Biocare Medical, LLC
    • Foundation Medicine, Inc.

第 11 章研究過程

  • 研究過程
    • 數據挖掘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 調查的特點
  • 調查先決條件

Global Liver Metastases Treatment Market is valued at approximately USD 1.2 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.2% over the forecast period 2022-2029. Liver Metastases are spread from an original Tumor or cancer to the liver. Liver Metastases do not begin with the Liver, they spread from other affected body parts. Cancers that spread to the liver cause Liver Metastases. Liver Metastases Treatment is the method used to cure Liver Metastases. Some of the common cancers that spread to the liver are breast cancer, colorectal cancer, esophageal cancer, and lung cancer. Increasing cases of breast and colorectal cancer, increasing government support and initiatives in cancer treatment, growing research and development, and rising incidence of target disease are the factors driving the growth of the market.

According to the World Cancer Research Fund, the global number of breast cancer cases was around 12.5% in the year 2020, whereas Lung cancer cases were around 12.2% in the same year. With 1.9 million new cases in 2020, colorectal cancer ranked third among all cancer types and accounted for 10.7% of all cases. Additionally, World Health Organisation unveiled a new global breast cancer initiative framework in February 2023, to achieve the goal of preventing 2.5 million deaths from breast cancer by 2040. The increasing cases of breast and colorectal cancer and increasing government support and initiatives are the major factors driving the growth of the market. Other important components driving market increase are growing research and development and the rising incidence of the target disease. Technological advancements in Liver Metastases Treatment and increasing R&D in healthcare are creating major market opportunities in the forecast period. However, the high cost of Liver Metastases Treatment stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Liver Metastases Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the availability of advanced treatment options for cancer, favorable government policies for cancer, and the high prevalence of liver metastases in the country such as the US. For instance, there are around 140,000 liver metastases cases annually in the US. Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as increasing healthcare expenditure, easy access to healthcare facilities, and lack of effective screening practices in the region.

Major market players included in this report are:

  • F. Hoffmann - La Roche Ltd.
  • AstraZeneca
  • Bayer AG
  • Eli Lilly and Company
  • Ono Pharmaceutical
  • Pfizer, Inc.
  • Bristol - Myers Squibb Company
  • Cadila Pharmaceuticals Ltd.
  • Biocare Medical, LLC
  • Foundation Medicine, Inc.

Recent Developments in the Market:

  • In March 2020, Nivolumab and ipilimumab were given rapid approval by the Food and Drug Administration to Ono Pharmaceuticals for the treatment of patients with hepatocellular carcinoma (HCC) who had previously been diagnosed with sorafenib.
  • In May 2020, atezolizumab and bevacizumab have been given FDA approval for the treatment of adult patients with unresectable locally advanced or metastatic hepatocellular carcinoma (HCC) who have not had any prior systemic therapy.

Global Liver Metastases Treatment Market Report Scope:

  • Historical Data 2019-2020-2021
  • Base Year for Estimation 2021
  • Forecast period 2022-2029
  • Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered Type, Primary Cancer, Distribution Channel, Region
  • Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Type offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy

By Primary Cancer:

  • Colorectal Cancer
  • Breast Cancer

By Distribution Channel:

  • Hospital Pharmacies
  • Specialty Pharmacies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Liver Metastases Treatment Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Liver Metastases Treatment Market, by Type, 2019-2029 (USD Billion)
    • 1.2.3. Liver Metastases Treatment Market, by Primary Cancer, 2019-2029 (USD Billion)
    • 1.2.4. Liver Metastases Treatment Market, by Distribution Channel, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Liver Metastases Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Liver Metastases Treatment Market Dynamics

  • 3.1. Liver Metastases Treatment Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing cases of breast and colorectal cancer
      • 3.1.1.2. Increasing government support and initiatives in cancer treatment
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Liver Metastases Treatment
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Technological advancements in Liver Metastases Treatment
      • 3.1.3.2. Increasing R&D in healthcare

Chapter 4. Global Liver Metastases Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Liver Metastases Treatment Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Liver Metastases Treatment Market by Type, Performance - Potential Analysis
  • 6.3. Global Liver Metastases Treatment Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
  • 6.4. Liver Metastases Treatment Market, Sub Segment Analysis
    • 6.4.1. Chemotherapy
    • 6.4.2. Targeted Therapy
    • 6.4.3. Immunotherapy

Chapter 7. Global Liver Metastases Treatment Market, by Primary Cancer

  • 7.1. Market Snapshot
  • 7.2. Global Liver Metastases Treatment Market by Primary Cancer, Performance - Potential Analysis
  • 7.3. Global Liver Metastases Treatment Market Estimates & Forecasts by Primary Cancer 2019-2029 (USD Billion)
  • 7.4. Liver Metastases Treatment Market, Sub Segment Analysis
    • 7.4.1. Colorectal Cancer
    • 7.4.2. Breast Cancer

Chapter 8. Global Liver Metastases Treatment Market, by Distribution Channel

  • 8.1. Market Snapshot
  • 8.2. Global Liver Metastases Treatment Market by Distribution Channel, Performance - Potential Analysis
  • 8.3. Global Liver Metastases Treatment Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
  • 8.4. Liver Metastases Treatment Market, Sub Segment Analysis
    • 8.4.1. Hospital Pharmacies
    • 8.4.2. Specialty Pharmacies

Chapter 9. Global Liver Metastases Treatment Market, Regional Analysis

  • 9.1. Liver Metastases Treatment Market, Regional Market Snapshot
  • 9.2. North America Liver Metastases Treatment Market
    • 9.2.1. U.S. Liver Metastases Treatment Market
      • 9.2.1.1. Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Primary Cancer breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Liver Metastases Treatment Market
  • 9.3. Europe Liver Metastases Treatment Market Snapshot
    • 9.3.1. U.K. Liver Metastases Treatment Market
    • 9.3.2. Germany Liver Metastases Treatment Market
    • 9.3.3. France Liver Metastases Treatment Market
    • 9.3.4. Spain Liver Metastases Treatment Market
    • 9.3.5. Italy Liver Metastases Treatment Market
    • 9.3.6. Rest of Europe Liver Metastases Treatment Market
  • 9.4. Asia-Pacific Liver Metastases Treatment Market Snapshot
    • 9.4.1. China Liver Metastases Treatment Market
    • 9.4.2. India Liver Metastases Treatment Market
    • 9.4.3. Japan Liver Metastases Treatment Market
    • 9.4.4. Australia Liver Metastases Treatment Market
    • 9.4.5. South Korea Liver Metastases Treatment Market
    • 9.4.6. Rest of Asia Pacific Liver Metastases Treatment Market
  • 9.5. Latin America Liver Metastases Treatment Market Snapshot
    • 9.5.1. Brazil Liver Metastases Treatment Market
    • 9.5.2. Mexico Liver Metastases Treatment Market
  • 9.6. Rest of The World Liver Metastases Treatment Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. F. Hoffmann - La Roche Ltd.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. AstraZeneca
    • 10.2.3. Bayer AG
    • 10.2.4. Eli Lilly and Company
    • 10.2.5. Ono Pharmaceutical
    • 10.2.6. Pfizer, Inc.
    • 10.2.7. Bristol - Myers Squibb Company
    • 10.2.8. Cadila Pharmaceuticals Ltd.
    • 10.2.9. Biocare Medical, LLC
    • 10.2.10. Foundation Medicine, Inc.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Liver Metastases Treatment Market, report scope
  • TABLE 2. Global Liver Metastases Treatment Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Liver Metastases Treatment Market estimates & forecasts by Type 2019-2029 (USD Billion)
  • TABLE 4. Global Liver Metastases Treatment Market estimates & forecasts by Primary Cancer 2019-2029 (USD Billion)
  • TABLE 5. Global Liver Metastases Treatment Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
  • TABLE 6. Global Liver Metastases Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Liver Metastases Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Liver Metastases Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Liver Metastases Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Liver Metastases Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Liver Metastases Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Liver Metastases Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Liver Metastases Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Liver Metastases Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Liver Metastases Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Liver Metastases Treatment Market
  • TABLE 71. List of primary sources, used in the study of global Liver Metastases Treatment Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Liver Metastases Treatment Market, research methodology
  • FIG 2. Global Liver Metastases Treatment Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Liver Metastases Treatment Market, key trends 2021
  • FIG 5. Global Liver Metastases Treatment Market, growth prospects 2022-2029
  • FIG 6. Global Liver Metastases Treatment Market, porters 5 force model
  • FIG 7. Global Liver Metastases Treatment Market, pest analysis
  • FIG 8. Global Liver Metastases Treatment Market, value chain analysis
  • FIG 9. Global Liver Metastases Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Liver Metastases Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Liver Metastases Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Liver Metastases Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Liver Metastases Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Liver Metastases Treatment Market, regional snapshot 2019 & 2029
  • FIG 15. North America Liver Metastases Treatment Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Liver Metastases Treatment Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Liver Metastases Treatment Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Liver Metastases Treatment Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Liver Metastases Treatment Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable